Alcon (ALC) Stock Forecast, Price Target & Predictions
ALC Stock Forecast
Alcon stock forecast is as follows: an average price target of $93.34 (represents a -5.24% downside from ALC’s last price of $98.50) and a rating consensus of 'Buy', based on 14 wall street analysts offering a 1-year stock forecast.
ALC Price Target
ALC Analyst Ratings
Alcon Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 22, 2024 | Larry Biegelsen | Wells Fargo | $105.00 | $95.56 | 9.88% | 6.60% |
Aug 22, 2024 | Steven Lichtman | Oppenheimer | $110.00 | $95.56 | 15.11% | 11.68% |
Aug 22, 2024 | Jeff Johnson | Robert W. Baird | $110.00 | $95.56 | 15.11% | 11.68% |
Aug 22, 2024 | David Saxon | Needham | $107.00 | $95.56 | 11.97% | 8.63% |
Jul 15, 2024 | Patrick Wood | Morgan Stanley | $85.00 | $89.96 | -5.51% | -13.71% |
May 16, 2024 | Anthony Petrone | Mizuho Securities | $105.00 | $89.97 | 16.71% | 6.60% |
May 15, 2024 | Steve Lichtman | Oppenheimer | $103.00 | $89.28 | 15.37% | 4.57% |
May 15, 2024 | Jeff Johnson | Robert W. Baird | $104.00 | $89.28 | 16.49% | 5.58% |
May 15, 2024 | Larry Biegelsen | Wells Fargo | $94.00 | $89.28 | 5.29% | -4.57% |
May 14, 2024 | Tom Stephan | Stifel Nicolaus | $100.00 | $89.28 | 12.01% | 1.52% |
Alcon Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 4 | 5 | 16 |
Avg Price Target | $108.00 | $103.40 | $99.56 |
Last Closing Price | $98.50 | $98.50 | $98.50 |
Upside/Downside | 9.64% | 4.97% | 1.08% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Sep 12, 2024 | BTIG | Buy | Buy | Hold |
Sep 10, 2024 | RBC Capital | - | Outperform | Upgrade |
Aug 22, 2024 | Needham | Buy | Buy | Hold |
Aug 22, 2024 | Oppenheimer | Outperform | Outperform | Hold |
Aug 22, 2024 | Wells Fargo | Overweight | Overweight | Hold |
Aug 22, 2024 | BTIG | Buy | Buy | Hold |
Jul 15, 2024 | BTIG | Buy | Buy | Hold |
May 15, 2024 | Oppenheimer | - | Outperform | Upgrade |
May 15, 2024 | Wells Fargo | Overweight | Overweight | Hold |
May 14, 2024 | Jefferies | Buy | Buy | Hold |
Alcon Financial Forecast
Alcon Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.35B | $2.17B | $2.14B | $2.22B | $2.19B | $2.15B | $2.10B | $2.11B | $1.93B | $1.94B | $1.84B | $1.21B | $1.84B | $1.91B | $1.87B |
Avg Forecast | $2.88B | $2.82B | $2.83B | $2.77B | $2.68B | $2.62B | $2.66B | $2.59B | $2.53B | $2.47B | $2.50B | $2.46B | $2.42B | $2.29B | $2.33B | $2.22B | $2.19B | $2.09B | $2.25B | $2.12B | $2.11B | $2.01B | $1.92B | $1.89B | $1.93B | $1.67B | $1.21B | $1.72B | $1.91B | $1.81B |
High Forecast | $2.91B | $2.85B | $2.86B | $2.80B | $2.70B | $2.65B | $2.69B | $2.62B | $2.55B | $2.48B | $2.53B | $2.48B | $2.50B | $2.31B | $2.35B | $2.25B | $2.21B | $2.11B | $2.25B | $2.15B | $2.14B | $2.04B | $1.95B | $1.92B | $1.96B | $1.70B | $1.22B | $1.75B | $1.94B | $1.84B |
Low Forecast | $2.85B | $2.79B | $2.80B | $2.74B | $2.65B | $2.59B | $2.63B | $2.56B | $2.50B | $2.44B | $2.47B | $2.43B | $2.39B | $2.26B | $2.30B | $2.20B | $2.16B | $2.06B | $2.25B | $2.09B | $2.09B | $1.98B | $1.90B | $1.87B | $1.91B | $1.65B | $1.19B | $1.70B | $1.89B | $1.79B |
# Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 5 | 2 | 3 | 3 | 3 | 3 | 5 | 4 | 4 | 5 | 2 | 2 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.06% | 0.99% | 1.02% | 0.98% | 1.03% | 1.02% | 1.05% | 1.10% | 1.02% | 1.00% | 1.10% | 1.01% | 1.07% | 1.00% | 1.03% |
Alcon EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 5 | 2 | 3 | 3 | 3 | 3 | 5 | 4 | 4 | 5 | 2 | 2 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $260.00M | $9.00M | $444.00M | $499.00M | $492.00M | $427.00M | $439.00M | $467.00M | $424.00M | $552.00M | $291.00M | $-65.00M | $337.00M | $274.00M | $355.00M |
Avg Forecast | $577.54M | $566.70M | $568.10M | $555.25M | $537.15M | $525.33M | $534.21M | $520.47M | $507.37M | $495.98M | $501.64M | $412.14M | $485.63M | $459.02M | $466.58M | $374.68M | $438.93M | $433.62M | $451.73M | $340.62M | $366.00M | $394.20M | $325.81M | $386.31M | $552.00M | $237.11M | $-35.75M | $227.97M | $279.96M | $258.00M |
High Forecast | $583.49M | $572.54M | $573.96M | $560.97M | $542.68M | $530.74M | $539.71M | $525.83M | $512.60M | $498.00M | $506.81M | $494.57M | $502.23M | $463.75M | $471.39M | $449.61M | $443.45M | $520.35M | $451.73M | $408.74M | $439.20M | $473.04M | $390.98M | $463.57M | $662.40M | $284.53M | $-28.60M | $273.56M | $335.95M | $309.60M |
Low Forecast | $571.08M | $560.35M | $561.74M | $549.04M | $531.13M | $519.45M | $528.23M | $514.64M | $501.69M | $490.43M | $496.03M | $329.72M | $479.40M | $453.88M | $461.36M | $299.74M | $434.02M | $346.90M | $451.73M | $272.49M | $292.80M | $315.36M | $260.65M | $309.05M | $441.60M | $189.69M | $-42.90M | $182.38M | $223.97M | $206.40M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.69% | 0.02% | 1.02% | 1.10% | 1.44% | 1.17% | 1.11% | 1.43% | 1.10% | 1.00% | 1.23% | 1.82% | 1.48% | 0.98% | 1.38% |
Alcon Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 5 | 2 | 3 | 3 | 3 | 3 | 5 | 4 | 4 | 5 | 2 | 2 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $174.00M | $-97.00M | $116.00M | $148.00M | $168.00M | $139.00M | $2.00M | $151.00M | $84.00M | $95.00M | $-147.00M | $-422.00M | $-57.00M | $-91.00M | $-66.00M |
Avg Forecast | $502.38M | $482.48M | $487.45M | $487.45M | $434.90M | $424.65M | $429.17M | $425.86M | $393.82M | $367.59M | $358.77M | $140.73M | $348.36M | $320.24M | $315.43M | $127.94M | $211.31M | $1.98M | $286.03M | $116.31M | $119.14M | $1.80M | $105.35M | $76.53M | $95.00M | $-119.78M | $-232.10M | $-38.56M | $-92.98M | $-66.00M |
High Forecast | $509.11M | $488.95M | $493.98M | $493.98M | $440.73M | $430.34M | $434.92M | $431.57M | $399.10M | $377.80M | $363.58M | $168.88M | $358.61M | $324.53M | $319.66M | $153.53M | $214.14M | $2.37M | $286.03M | $139.57M | $142.97M | $2.16M | $126.42M | $91.84M | $114.00M | $-95.82M | $-185.68M | $-30.85M | $-74.38M | $-52.80M |
Low Forecast | $495.07M | $475.46M | $480.36M | $480.36M | $428.58M | $418.47M | $422.93M | $419.67M | $388.09M | $362.49M | $353.56M | $112.59M | $338.11M | $315.59M | $310.84M | $102.35M | $208.24M | $1.58M | $286.03M | $93.05M | $95.31M | $1.44M | $84.28M | $61.23M | $76.00M | $-143.73M | $-278.52M | $-46.27M | $-111.57M | $-79.20M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.36% | -0.46% | 58.72% | 0.52% | 1.44% | 1.17% | 1.11% | 1.43% | 1.10% | 1.00% | 1.23% | 1.82% | 1.48% | 0.98% | 1.00% |
Alcon SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 5 | 2 | 3 | 3 | 3 | 3 | 5 | 4 | 4 | 5 | 2 | 2 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $785.00M | $762.00M | $762.00M | $803.00M | $741.00M | $813.00M | $779.00M | $785.00M | $699.00M | $737.00M | $685.00M | $595.00M | $677.00M | $714.00M | $717.00M |
Avg Forecast | $1.06B | $1.04B | $1.04B | $1.02B | $982.90M | $961.28M | $977.52M | $952.38M | $928.41M | $907.57M | $917.93M | $620.73M | $888.63M | $839.94M | $853.77M | $564.30M | $803.18M | $769.46M | $826.60M | $513.00M | $696.86M | $699.51M | $547.67M | $636.87M | $737.00M | $558.15M | $327.25M | $457.97M | $729.52M | $717.00M |
High Forecast | $1.07B | $1.05B | $1.05B | $1.03B | $993.03M | $971.19M | $987.60M | $962.20M | $937.98M | $911.27M | $927.39M | $744.88M | $919.01M | $848.59M | $862.57M | $677.16M | $811.46M | $923.35M | $826.60M | $615.60M | $836.23M | $839.41M | $657.21M | $764.24M | $884.40M | $669.78M | $392.70M | $549.56M | $875.43M | $860.40M |
Low Forecast | $1.04B | $1.03B | $1.03B | $1.00B | $971.90M | $950.52M | $966.58M | $941.73M | $918.02M | $897.41M | $907.66M | $496.58M | $877.24M | $830.54M | $844.22M | $451.44M | $794.20M | $615.57M | $826.60M | $410.40M | $557.49M | $559.61M | $438.14M | $509.49M | $589.60M | $446.52M | $261.80M | $366.38M | $583.62M | $573.60M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.39% | 0.95% | 0.99% | 0.97% | 1.44% | 1.17% | 1.11% | 1.43% | 1.10% | 1.00% | 1.23% | 1.82% | 1.48% | 0.98% | 1.00% |
Alcon EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 9 | 4 | 6 | 4 | 3 | 7 | 5 | 2 | 3 | 3 | 3 | 3 | 5 | 4 | 4 | 5 | 2 | 2 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.35 | $-0.20 | $0.24 | $0.30 | $0.34 | $0.28 | - | $0.31 | $0.17 | $0.19 | $-0.30 | $-0.86 | $-0.12 | $-0.19 | $-0.14 |
Avg Forecast | $1.01 | $0.97 | $0.98 | $0.98 | $0.88 | $0.85 | $0.86 | $0.86 | $0.79 | $0.74 | $0.72 | $0.72 | $0.70 | $0.64 | $0.63 | $0.61 | $0.43 | $0.48 | $0.58 | $0.54 | $0.50 | $0.50 | $0.45 | $0.44 | $0.41 | $0.22 | $-0.09 | $0.35 | $0.46 | $0.45 |
High Forecast | $1.02 | $0.98 | $0.99 | $0.99 | $0.89 | $0.87 | $0.88 | $0.87 | $0.80 | $0.76 | $0.73 | $0.73 | $0.72 | $0.65 | $0.64 | $0.62 | $0.43 | $0.49 | $0.58 | $0.55 | $0.51 | $0.50 | $0.46 | $0.45 | $0.42 | $0.23 | $-0.09 | $0.35 | $0.47 | $0.46 |
Low Forecast | $1.00 | $0.96 | $0.97 | $0.97 | $0.86 | $0.84 | $0.85 | $0.84 | $0.78 | $0.73 | $0.71 | $0.71 | $0.68 | $0.63 | $0.63 | $0.60 | $0.42 | $0.47 | $0.58 | $0.53 | $0.49 | $0.49 | $0.44 | $0.44 | $0.41 | $0.22 | $-0.10 | $0.34 | $0.45 | $0.45 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.57% | -0.47% | 0.50% | 0.52% | 0.63% | 0.56% | 0.01% | 0.69% | 0.38% | 0.46% | -1.35% | 9.15% | -0.35% | -0.41% | -0.31% |
Alcon Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
COO | Cooper Companies | $110.53 | $298.00 | 169.61% | Buy |
ANGO | AngioDynamics | $7.64 | $17.00 | 122.51% | Buy |
BAX | Baxter | $39.72 | $64.62 | 62.69% | Hold |
HAE | Haemonetics | $76.09 | $104.33 | 37.11% | Buy |
TFX | Teleflex | $246.05 | $304.09 | 23.59% | Buy |
NVST | Envista | $19.41 | $23.83 | 22.77% | Hold |
WST | West Pharmaceutical Services | $300.67 | $345.33 | 14.85% | Buy |
BLFS | BioLife Solutions | $25.12 | $26.00 | 3.50% | Buy |
MMSI | Merit Medical Systems | $96.16 | $93.38 | -2.89% | Buy |
ALC | Alcon | $98.50 | $93.34 | -5.24% | Buy |
RMD | ResMed | $248.93 | $209.33 | -15.91% | Hold |
ICUI | ICU Medical | $179.00 | $135.00 | -24.58% | Buy |
EMBC | Embecta | $16.02 | $12.00 | -25.09% | Sell |
ATR | AptarGroup | $152.28 | $100.00 | -34.33% | Buy |
ALC Forecast FAQ
Is Alcon a good buy?
Yes, according to 14 Wall Street analysts, Alcon (ALC) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 13 'Buy' recommendations, accounting for 92.86% of ALC's total ratings.
What is ALC's price target?
Alcon (ALC) average price target is $93.34 with a range of $69 to $110, implying a -5.24% from its last price of $98.5. The data is based on 14 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Alcon stock go up soon?
According to Wall Street analysts' prediction for ALC stock, the company can go down by -5.24% (from the last price of $98.5 to the average price target of $93.34), up by 11.68% based on the highest stock price target, and down by -29.95% based on the lowest stock price target.
Can Alcon stock reach $150?
ALC's average twelve months analyst stock price target of $93.34 does not support the claim that Alcon can reach $150 in the near future.
What is Alcon's current price target trend?
4 Wall Street analysts forecast a $108 price target for Alcon (ALC) this month, up 9.64% from its last price of $98.5. Compared to the last 3 and 12 months, the average price target increased by 4.97% and increased by 1.08%, respectively.
What are Alcon's analysts' financial forecasts?
Alcon's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $10.55B (high $10.66B, low $10.43B), average EBITDA is $2.12B (high $2.14B, low $2.09B), average net income is $1.71B (high $1.74B, low $1.69B), average SG&A $3.87B (high $3.91B, low $3.83B), and average EPS is $3.45 (high $3.5, low $3.4). ALC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $11.3B (high $11.42B, low $11.17B), average EBITDA is $2.27B (high $2.29B, low $2.24B), average net income is $1.96B (high $1.99B, low $1.93B), average SG&A $4.15B (high $4.19B, low $4.1B), and average EPS is $3.94 (high $4, low $3.89).
Did the ALC's actual financial results beat the analysts' financial forecasts?
Based on Alcon's last annual report (Dec 2022), the company's revenue was $8.72B, beating the average analysts forecast of $8.64B by 0.84%. Apple's EBITDA was $1.72B, beating the average prediction of $1.66B by 3.31%. The company's net income was $335M, missing the average estimation of $615.62M by -45.58%. Apple's SG&A was $3.07B, beating the average forecast of $2.91B by 5.35%. Lastly, the company's EPS was $0.68, missing the average prediction of $2.02 by -66.32%. In terms of the last quarterly report (Mar 2023), Alcon's revenue was $2.35B, beating the average analysts' forecast of $2.22B by 5.83%. The company's EBITDA was $260M, missing the average prediction of $374.68M by -30.61%. Alcon's net income was $174M, beating the average estimation of $127.94M by 36.00%. The company's SG&A was $785M, beating the average forecast of $564.3M by 39.11%. Lastly, the company's EPS was $0.35, missing the average prediction of $0.61 by -42.58%